Key result
Anticoagulant choice drives the greatest variation in plasma metabolome profiles, favoring EDTA processed within 24 hours.
Answers are grounded in this paper and cite their sources.
Liquid-chromatography mass spectrometry is commonly used to identify and quantify metabolites from biological samples to gain insight into human physiology and pathology. Metabolites and their abundance in biological samples are labile and sensitive to variations in collection conditions, handling and processing. Variations in sample handling could influence metabolite levels in ways not related to biology, ultimately leading to the misinterpretation of results. For example, anticoagulants and preservatives modulate enzyme activity and metabolite oxidization. Temperature may alter both enzymatic and non-enzymatic chemistry. The potential for variation induced by collection conditions is particularly important when samples are collected in remote locations without immediate access to specimen processing. Data are needed regarding the variation introduced by clinical sample collection processes to avoid introducing artifact biases. In this study, we used metabolomics and lipidomics approaches paired with univariate and multivariate statistical analyses to assess the effects of anticoagulant, temperature, and time on healthy human plasma samples collected to provide guidelines on sample collection, handling, and processing for vaccinology. Principal component analyses demonstrated clustering by sample collection procedure and that anticoagulant type had the greatest effect on sample metabolite variation. Lipids such as glycerophospholipids, acylcarnitines, sphingolipids, diacylglycerols, triacylglycerols, and cholesteryl esters are significantly affected by anticoagulant type as are amino acids such as aspartate, histidine, and glutamine. Most plasma metabolites and lipids were unaffected by storage time and temperature. Based on this study, we recommend samples be collected using a single anticoagulant (preferably EDTA) with sample processing at <24 h at 4 °C.
No takes yet. Share an insight, caveat, or question.
Khadka et al. (2019) studied Healthy donors. Sample collection and processing conditions (anticoagulant type, storage temperature, and time) vs. Different anticoagulants (including EDTA), temperatures, and processing times was evaluated on Variation in human plasma metabolome and lipidome profiles determined by LC-MS. Anticoagulant type had the greatest effect on plasma metabolite and lipid variation, supporting EDTA collection with processing at <24 h at 4 °C.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: